Developments and applications of functional protein microarrays
Protein microarrays are crucial tools in the study of proteins in an unbiased, high-throughput
manner, as they allow for characterization of up to thousands of individually purified proteins …
manner, as they allow for characterization of up to thousands of individually purified proteins …
Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
J Zhang, C Chen, A Li, W Jing, P Sun, X Huang… - Nature …, 2021 - nature.com
Immunotherapies have revolutionized intervention strategies for many primary cancers, but
have not improved the outcomes of glioblastoma multiforme (GBM), which remains one of …
have not improved the outcomes of glioblastoma multiforme (GBM), which remains one of …
Advances in the development of human protein microarrays
JG Duarte, JM Blackburn - Expert review of proteomics, 2017 - Taylor & Francis
Introduction: High-content protein microarrays in principle enable the functional interrogation
of the human proteome in a broad range of applications, including biomarker discovery …
of the human proteome in a broad range of applications, including biomarker discovery …
Anti-cancer auto-antibodies: Roles, applications and open issues
Simple Summary Cancer is one of the main causes of death worldwide and early detection
is crucial for effective treatment. Scientists have therefore focused on the identification of …
is crucial for effective treatment. Scientists have therefore focused on the identification of …
Identification of serological biomarkers for early diagnosis of lung cancer using a protein array-based approach
Lung cancer (LC) remains the leading cause of mortality from malignant tumors worldwide.
Currently, a lack of serological biomarkers for early LC diagnosis is a major roadblock for …
Currently, a lack of serological biomarkers for early LC diagnosis is a major roadblock for …
[HTML][HTML] Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as …
I Jovčevska, N Zupanec, Ž Urlep, A Vranič, B Matos… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Glioblastoma multiforme is the most frequent primary malignancy of the central nervous
system. Despite remarkable progress towards an understanding of tumor biology, there is no …
system. Despite remarkable progress towards an understanding of tumor biology, there is no …
The plasma peptides of Alzheimer's disease
A Florentinus-Mefailoski, P Bowden, P Scheltens… - Clinical Proteomics, 2021 - Springer
Background A practical strategy to discover proteins specific to Alzheimer's dementia (AD)
may be to compare the plasma peptides and proteins from patients with dementia to normal …
may be to compare the plasma peptides and proteins from patients with dementia to normal …
A protein microarray‐based serum proteomic investigation reveals distinct autoantibody signature in colorectal cancer
A Barpanda, C Tuckley, A Ray… - PROTEOMICS …, 2023 - Wiley Online Library
Purpose Colorectal cancer (CRC) has been reported as the second leading cause of cancer
death worldwide. The 5‐year annual survival is around 50%, mainly due to late diagnosis …
death worldwide. The 5‐year annual survival is around 50%, mainly due to late diagnosis …
Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis
M Garranzo-Asensio, P San Segundo-Acosta… - Journal of …, 2020 - Elsevier
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of
cancer related death worldwide. Its diagnosis at early stages would significantly improve the …
cancer related death worldwide. Its diagnosis at early stages would significantly improve the …
Development of autoantibody signatures for common cancers
M Kobayashi, H Katayama, JF Fahrmann… - Seminars in …, 2020 - Elsevier
A humoral immune response in the form of autoantibodies to tumor antigens occurs early
during tumor development. Identification of antigens that induce an autoantibody response …
during tumor development. Identification of antigens that induce an autoantibody response …